DE60029369D1 - Verfahren und Sondenset zur Erkennung von Krebs - Google Patents

Verfahren und Sondenset zur Erkennung von Krebs

Info

Publication number
DE60029369D1
DE60029369D1 DE60029369T DE60029369T DE60029369D1 DE 60029369 D1 DE60029369 D1 DE 60029369D1 DE 60029369 T DE60029369 T DE 60029369T DE 60029369 T DE60029369 T DE 60029369T DE 60029369 D1 DE60029369 D1 DE 60029369D1
Authority
DE
Germany
Prior art keywords
cancer
procedure
detection
probe set
chromosomal probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029369T
Other languages
English (en)
Other versions
DE60029369T2 (de
Inventor
Kevin C Halling
Robert B Jenkins
Walter King
Irina A Sokolova
Steven A Seelig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Abbott Molecular Inc
Original Assignee
Mayo Foundation for Medical Education and Research
Vysis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research, Vysis Inc filed Critical Mayo Foundation for Medical Education and Research
Application granted granted Critical
Publication of DE60029369D1 publication Critical patent/DE60029369D1/de
Publication of DE60029369T2 publication Critical patent/DE60029369T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/16—Assays for determining copy number or wherein the copy number is of special importance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
DE60029369T 1999-03-05 2000-03-03 Verfahren und Sondenset zur Erkennung von Krebs Expired - Lifetime DE60029369T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/264,149 US6174681B1 (en) 1999-03-05 1999-03-05 Method and probe set for detecting cancer
US264149 2002-10-03

Publications (2)

Publication Number Publication Date
DE60029369D1 true DE60029369D1 (de) 2006-08-31
DE60029369T2 DE60029369T2 (de) 2007-07-12

Family

ID=23004816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029369T Expired - Lifetime DE60029369T2 (de) 1999-03-05 2000-03-03 Verfahren und Sondenset zur Erkennung von Krebs

Country Status (7)

Country Link
US (9) US6174681B1 (de)
EP (2) EP1650313B1 (de)
JP (4) JP4986316B2 (de)
AT (1) ATE333517T1 (de)
DE (1) DE60029369T2 (de)
DK (1) DK1650313T3 (de)
ES (1) ES2528180T3 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878552A1 (de) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
WO1999057309A1 (en) * 1998-05-04 1999-11-11 Dako A/S Method and probes for the detection of chromosome aberrations
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
AU2001281136A1 (en) * 2000-08-04 2002-02-18 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
EP1362124B1 (de) * 2001-02-20 2011-07-06 Vysis, Inc. Verfahren und sonden für den nachweis von krebs
MXPA04008477A (es) * 2002-03-01 2005-10-26 Ravgen Inc Metodos para deteccion de trastornos geneticos.
US6977162B2 (en) * 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
US20070178478A1 (en) * 2002-05-08 2007-08-02 Dhallan Ravinder S Methods for detection of genetic disorders
US7442506B2 (en) * 2002-05-08 2008-10-28 Ravgen, Inc. Methods for detection of genetic disorders
US7727720B2 (en) * 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US7217515B2 (en) * 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
US7267648B2 (en) * 2003-03-31 2007-09-11 Olympus Corporation Magnifying image pickup unit for an endoscope, an endoscope for in vivo cellular observation that uses it, and endoscopic, in vivo cellular observation methods
US20040197839A1 (en) * 2003-04-04 2004-10-07 Bioview Ltd. Methods of detecting cancer cells in biological samples
CA2501792C (en) 2003-06-09 2017-06-20 Vysis, Inc. Detection of high grade dysplasia in cervical cells
US20040248107A1 (en) * 2003-06-09 2004-12-09 Sokolova Irina A. Detection of high grade dysplasia in cervical cells
WO2005072133A2 (en) * 2004-01-27 2005-08-11 Zoragen, Inc. Nucleic acid detection
US9706997B2 (en) * 2004-08-27 2017-07-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20060047337A1 (en) 2004-08-27 2006-03-02 Brenneman Rodney A Device and method for establishing an artificial arterio-venous fistula
US7828814B2 (en) * 2004-08-27 2010-11-09 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20090162839A1 (en) * 2004-08-31 2009-06-25 Board Of Regents, The University Of Texas System Diagnosis and prognosis of cancer based on telomere length as measured on cytological specimens
US8226592B2 (en) * 2004-12-15 2012-07-24 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
EP1853729B1 (de) * 2005-02-18 2014-12-03 Abbott Laboratories Verfahren und sonden zur erkennung von speiseröhrenkrebs
CA2599445C (en) 2005-03-09 2022-05-03 Abbott Laboratories Diagnostics method for identifying candidate patients for the treatment with trastuzumab
JP2009507227A (ja) * 2005-09-02 2009-02-19 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア メラノーマを診断するための方法及びプローブ組み合わせ
WO2007087612A2 (en) * 2006-01-25 2007-08-02 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
US20080026366A1 (en) * 2006-06-07 2008-01-31 Newcomer Supply, Inc. Biological fixative and method of using the biological fixative
US7960110B2 (en) 2006-11-15 2011-06-14 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
WO2009015359A2 (en) * 2007-07-26 2009-01-29 Cellay, Llc Highly visible chromosome-specific probes and related methods
US20090258365A1 (en) * 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
US20090280491A1 (en) * 2008-03-27 2009-11-12 The Trustees Of Columbia University In The City Of New York Predicting cancer invasiveness
WO2010039862A1 (en) * 2008-09-30 2010-04-08 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
US8785131B2 (en) * 2008-11-11 2014-07-22 Abbott Laboratories Prognostic test for early stage non small cell lung cancer (NSCLC)
FR2938269B1 (fr) * 2008-11-13 2012-09-28 Array Genomics Procede de detection urinaire du cancer de la vessie
US20100129796A1 (en) * 2008-11-24 2010-05-27 Micah Halpern Dye probe fluorescence resonance energy transfer genotyping
CN105586433A (zh) * 2009-10-26 2016-05-18 雅培制药有限公司 用于测定非小细胞肺癌预后的诊断方法
US9291625B2 (en) 2009-10-26 2016-03-22 Abbott Laboratories Diagnostic methods for determining prognosis of non-small cell lung cancer
DE102011100242A1 (de) 2011-05-02 2012-11-08 Zytovision Gmbh Verfahren zur Detektion von Chromosomenaberration
JP6284487B2 (ja) 2011-12-30 2018-02-28 アボツト・モレキユラー・インコーポレイテツド 膀胱癌の診断及びその再発のモニタリングのための材料及び方法
US10087486B2 (en) 2012-11-09 2018-10-02 The Regents Of The University Of California Methods for predicting age and identifying agents that induce or inhibit premature aging
EP3105351B1 (de) 2014-02-12 2019-06-26 Leica Biosystems Newcastle Limited Kit und verfahren zum nachweis von blasenkrebs
ES2702603T3 (es) 2015-06-23 2019-03-04 Zytovision Gmbh Procedimiento para la detección de aberraciones cromosómicas
EP3130680A1 (de) 2015-08-11 2017-02-15 Universitat de Girona Verfahren zur detektion, nachverfolgung und/oder klassifikation von darmerkrankungen
WO2019152504A1 (en) 2018-01-30 2019-08-08 Board Of Regents, The University Of Texas System Multi-color fish test for bladder cancer detection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756696A (en) * 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5028525A (en) * 1986-11-24 1991-07-02 Regents Of The University Of California Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ
US5874234A (en) * 1990-08-01 1999-02-23 Johns Hopkins University Assay for a novel mammalian protein associated with uncontrolled cell division
US5491224A (en) 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
ATE205542T1 (de) * 1992-03-04 2001-09-15 Univ California Vergleichende genomhybridisierung
WO1994009022A1 (en) 1992-10-09 1994-04-28 Oncor, Inc. Methods for the detection of chromosome structural abnormalities by in situ hybridization to fixed tissue
WO1995013398A1 (en) 1993-11-12 1995-05-18 Oncor, Inc. Detection of bladder cancer
AU685627B2 (en) * 1994-03-18 1998-01-22 Myriad Genetics, Inc. Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
EP0879297A4 (de) * 1995-12-22 2003-04-16 Biorad Lab Inc Verfahren und gerät zur durchführung von fluoreszenz in situ hybridisierung unter messung einer vielzahl von parametern
US5759781A (en) * 1995-12-22 1998-06-02 Yale University Multiparametric fluorescence in situ hybridization
GB9704054D0 (en) * 1997-02-27 1997-04-16 Univ Cambridge Tech Assay
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer

Also Published As

Publication number Publication date
US7232655B2 (en) 2007-06-19
EP1035215A3 (de) 2000-09-20
ATE333517T1 (de) 2006-08-15
EP1650313A1 (de) 2006-04-26
JP2017131248A (ja) 2017-08-03
US20120276540A1 (en) 2012-11-01
DE60029369T2 (de) 2007-07-12
US9045802B2 (en) 2015-06-02
DK1650313T3 (en) 2015-01-26
US20110177510A1 (en) 2011-07-21
JP5680502B2 (ja) 2015-03-04
JP2000270900A (ja) 2000-10-03
US6376188B1 (en) 2002-04-23
US6174681B1 (en) 2001-01-16
JP2011224021A (ja) 2011-11-10
EP1650313B1 (de) 2014-11-05
EP1035215A2 (de) 2000-09-13
JP6170024B2 (ja) 2017-07-26
US9790558B2 (en) 2017-10-17
ES2528180T3 (es) 2015-02-05
EP1035215B1 (de) 2006-07-19
US20130316344A1 (en) 2013-11-28
US8785129B2 (en) 2014-07-22
JP2015015958A (ja) 2015-01-29
US20020160409A1 (en) 2002-10-31
US20150337391A1 (en) 2015-11-26
JP4986316B2 (ja) 2012-07-25
US20080032302A1 (en) 2008-02-07
US7998670B2 (en) 2011-08-16
US20150072884A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
ATE350488T1 (de) Verfahren und testsysteme zur identifizierung von elite event gat-zm1 in biologischen proben
WO2000077260A8 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
DK0979308T3 (da) Fremgangsåde til fremstilling af et diagnostisk standard gen-transkriptmönster
ATE219245T1 (de) Biosensor, iontophoretischen probenahmesystem, und verfahren zur seiner anwendung
DE50115173D1 (de) Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens 2 verschiedenen molekularen Markern
ATE337413T1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
HUP0303888A2 (hu) FKBP-nukleinsavak és -polipeptidek prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
WO2002022879A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
ATE264922T1 (de) Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe
DK1631686T3 (da) Påvisning af dysplasi i høj grad i cervicale celler
DE60142898D1 (de) Diagnostisches kit zur identifikation und feststellung von wirkstoffresistenz bei mykobakterium sowie herstellungsmethoden davon
ATE321886T1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
ATE229571T1 (de) Nachweis und identifizierung von nicht-polio enteroviren
ATE293707T1 (de) Nukelinsäure primer und proben zum nachweis von tumorzellen
DE60136277D1 (de) Verfahren zum nachweis von krebs
ATE494390T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
ATE415491T1 (de) Oligonucleotide zur markierung von oligonukleotidsonden und proteine
DE60129015D1 (de) Verfahren zur erkennung von entzündungen und entzündungsbedingungen
ATE486964T1 (de) Molekulares verfahren zur diagnose von prostatakrebs
HUP0303890A2 (hu) Differenciációs nukleinsavak és polipeptidek inhibitorának prosztatarák diagnosztizálására és gyógykezelésére alkalmas expressziós analízise

Legal Events

Date Code Title Description
8364 No opposition during term of opposition